Jun 17 |
Estimating The Intrinsic Value Of Belite Bio, Inc (NASDAQ:BLTE)
|
Jun 12 |
Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japan
|
May 15 |
Belite Bio, Inc 2024 Q1 - Results - Earnings Call Presentation
|
May 15 |
Belite Bio, Inc (BLTE) Q1 2024 Earnings Call Transcript
|
May 14 |
Belite Bio reports Q1 results
|
May 14 |
Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference
|
May 14 |
Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
|
May 13 |
Belite Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
|
May 8 |
Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results
|
May 6 |
Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease (STGD1) and Geographic Atrophy (GA) and Perspectives On Tinlarebant
|